Nayfeh M Jr, Al-Mallah MH. Reassessing the role of ischemia imaging: insights from the ISCHEMIA trial. Nucl Med Mol Imaging. 2024;58:392–9.

Article  PubMed  Google Scholar 

Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–407.

Article  PubMed  PubMed Central  Google Scholar 

Hochman JS, Anthopolos R, Reynolds HR, Bangalore S, Xu Y, O’Brien SM, et al. Survival after invasive or conservative management of stable coronary disease. Circulation. 2023;147:8–19.

Article  PubMed  Google Scholar 

Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.

Article  CAS  PubMed  Google Scholar 

Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503–15.

Bangalore S, Maron DJ, Stone GW, Hochman JS. Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials. Circulation. 2020;142:841–57.

Article  PubMed  Google Scholar 

Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, et al. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction. J Am Coll Cardiol. 2012;60:2296–304.

Article  PubMed  Google Scholar 

Bangalore S, Pencina MJ, Kleiman NS, Cohen DJ. Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Am Heart J. 2013;166:1027–34.

Article  PubMed  Google Scholar 

Gould KL, Johnson NP, Roby AE, Nguyen T, Kirkeeide R, Haynie M, et al. Regional, artery-specific thresholds of quantitative myocardial perfusion by PET associated with reduced myocardial infarction and death after revascularization in stable coronary artery disease. J Nucl Med. 2019;60:410–7.

Article  PubMed  PubMed Central  Google Scholar 

Gould KL, Kitkungvan D, Johnson NP, Nguyen T, Kirkeeide R, Bui L, et al. Mortality prediction by quantitative PET perfusion expressed as coronary flow capacity with and without revascularization. JACC Cardiovasc Imaging. 2021;14:1020–34.

Article  PubMed  Google Scholar 

de Winter RW, Jukema RA, van Diemen PA, Schumacher SP, Driessen RS, Stuijfzand WJ, et al. The impact of coronary revascularization on vessel-specific coronary flow capacity and long-term outcomes: a serial [15O]H2O positron emission tomography perfusion imaging study. Eur Heart J Cardiovasc Imaging. 2022;23:743–52.

Article  PubMed  Google Scholar 

Choe YH, Kim SM. Recent progress of cardiac MRI for nuclear medicine professionals. Nucl Med Mol Imaging. 2024;58:431–48.

Article  PubMed  Google Scholar 

Ko SM. Current status of cardiac CT for nuclear medicine professionals: coronary artery disease evaluation. Nucl Med Mol Imaging. 2024;58:418–30.

Article  PubMed  Google Scholar 

Ha S, Han S. The role of lung ventilation/perfusion scan in the management of chronic thromboembolic pulmonary hypertension. Nucl Med Mol Imaging. 2024;58:449–58.

Article  PubMed  Google Scholar 

Cho SG. Can FDG PET serve as a clinically relevant tool for detecting active non-sarcoidotic myocarditis? Nucl Med Mol Imaging. 2024;58:406–17.

Article  PubMed  Google Scholar 

Bullock-Palmer RP, Flores Rosario K, Douglas PS, Hahn RT, Lang RM, Chareonthaitawee P, et al. Multimodality cardiac imaging and the imaging workforce in the United States: diversity, disparities, and future directions. Circ Cardiovasc Imaging. 2024;17:e016409.

Article  PubMed  Google Scholar 

Jo KH, Kang WJ. Recent progress in myocardial perfusion imaging techniques. Nucl Med Mol Imaging. 2024;58:400–5.

Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM, ACCF/AHA/ASE/, ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS, American Heart Association. 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;63:380–406.